Aaron Gerds, MD

216.444.6833

https://youtu.be/U7Oxwamra3Q
4.9 out of 5
66 Patient Satisfaction Ratings 3 Comments
Aaron Gerds, MD
Department: Hematology and Oncology
Associate Staff
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
WorkFax:216.444.9464
Surgeon:
No
Type of Doctor:
Adults Only

Biographical Sketch

Dr. Aaron Gerds completed his undergraduate degree with honors (B.A. in biology and chemistry) at Hope College in Holland, Michigan. He then obtained his M.D. from Loyola University Chicago Stritch School of Medicine. Dr. Gerds stayed at Loyola University Hospital for his Internal Medicine residency training where he also served as chief resident. This is when he first became interested in hematology while analyzing the results of clinical trials under the mentorship of Dr. Patrick Stiff. This experience led him to pursue a master’s degree in clinical research methods and epidemiology during residency. Dr. Gerds then went to Seattle where he completed his hematology/oncology fellowship at the University of Washington, Fred Hutchinson Cancer Research Center. During his fellowship, he was awarded the ASBMT’s New Investigator Award. Under the mentorship of Drs. Joachim Deeg and Bart Scott, Dr. Gerds subspecialized in treating patients with myeloproliferative neoplasms (MPNs) such as polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), as well as myelodsyplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML), with a special emphasis on allogeneic hematopoietic cell transplantation. Dr. Gerds is also an active member of the American Society of Hematology, participating in both the Advocacy Leadership Institute and Clinical Research Training Institute, as well as serving on the Test Materials Development Committee. As Assistant Professor in Medicine (Hematology and Medical Oncology) at the Cleveland Clinic Taussig Cancer Institute, Dr. Gerds serves as the principle investigator for a number of clinical trials for the treatment of MPNs, and is focused on developing novel therapies for these patients.

Education & Fellowships

Fellowship - University of Washington Medical Center
Hematology and Oncology
Seattle, WA USA
2013
Graduate - Loyola University
Chicago, IL USA
2011
Residency - Loyola University Medical Center
Internal Medicine
Maywood, IL USA
2010
Medical School - Loyola University Stritch School of Medicine
Chicago, IL USA
2006
Undergraduate - Hope College
Holland, MI USA
2002

Certifications

  • Internal Medicine
  • Internal Medicine- Medical Oncology
  • Internal Medicine- Hematology

Awards & Honors

  • Sigma Xi Senior Research Award, Hope College, April 18, 2002
  • Winner, National Medical Student Research Competition, American College of Physicians, April 24, 2004
  • Winner, Loyola Internal Medicine Clinical Vignette Competition, September 6, 2006
  • Resident of the Year, Loyola University Internal Medicine Residency, 2008 – 2009
  • Resident Teacher of the Year, Loyola University Internal Medicine Residency, 2008 – 2009
  • Alpha Omega Alpha, Loyola University Stritch School of Medicine, 2010
  • Scholar, American Society for Blood and Marrow Transplantation Clinical Research Training Course, July 16, 2012
  • New Investigator Award, American Society for Blood and Marrow Transplantation, February 15, 2013
  • Participant, American Society of Hematology Clinical Research Training Program, 2014
  • Participant, American Society of Hematology Advocacy Leadership Institute, 2014

Memberships

  • Member, 2010 – Present, Alpha Omega Alpha Medical Honor Society
  • Member, 2010 – Present, American Society of Clinical Oncology
  • Member, 2010 – Present, American Society of Hematology
  • Scholar Member, 2012 – 2013, Institute of Translational Health Sciences
  • Member, 2012 – Present, American Society for Blood and Marrow Transplantation
  • Member, 2012 – 2013, American Association for the Advancement of Science
  • Associate Member, 2013 – Present, Hematopoietic Disorders Program, Case Comprehensive Cancer Center
  • Member, 2013 – Present, MDS Foundation
  • Member, 2014 – Present, Society of Hematologic Oncology

Treatment & Services

  • Chemotherapy
  • Clinical Trials
  • Hematopoietic Stem Cell Transplantation

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/31/2015, Dr. Gerds has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English

Patient Satisfaction Reviews

Learn About Our Survey

Criteria

The Patient Satisfaction Rating is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.